These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36128470)

  • 1. Application of the international system for reporting serous fluid cytopathology on reporting various body fluids; experience of a tertiary care hospital.
    Kolte S; Zaheer S; Aden D; Ranga S
    Cytojournal; 2022; 19():52. PubMed ID: 36128470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Retrospective Analysis of the Application of the Newly Proposed International System for Reporting Serous Fluid Cytopathology on Serous Effusion Specimens: An Institutional Experience.
    Rajeswaran PK; Srinivasan V; Mahesh SSV; Ashok AU
    Acta Cytol; 2023; 67(1):70-79. PubMed ID: 36476509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology.
    Rodriguez EF; Jones R; Gabrielson M; Santos D; Pastorello RG; Maleki Z
    Acta Cytol; 2020; 64(5):477-485. PubMed ID: 32422631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy.
    Ahuja S; Malviya A
    Cytopathology; 2022 Mar; 33(2):176-184. PubMed ID: 34913541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
    Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
    Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of malignancy assessment of the International System for Reporting Serous Fluid Cytopathology: Experience in a community hospital setting and comparison with other studies.
    Sun T; Wang M; Wang H
    Cancer Cytopathol; 2022 Dec; 130(12):964-973. PubMed ID: 35994357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of international system for reporting serous fluid cytology (ISRSFC) in effusion samples-a prospective study in an oncology setting.
    Sachan R; Gupta A; Awasthi PN; Singh P; Anand N; Chandra S; Gaur G; Husain N; Sachan KD
    J Am Soc Cytopathol; 2023; 12(5):351-361. PubMed ID: 37244848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The International System for Reporting Serous Fluid Cytopathology: An Institutional Experience on its Implication and Assessment of Risk of Malignancy in Effusion Cytology.
    Kala C; Kala S; Singh A; Jauhari RK; Bajpai A; Khan L
    J Cytol; 2023; 40(4):159-164. PubMed ID: 38058672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Stratification of Pleural Fluid Cytology Based on the International System for Reporting Serous Fluid Cytology in a Tertiary Care Centre.
    Bharti S; Nalwa A; Elhence PA; Rao M; Bharti JN; Khera S; Vedant D; Vishwajeet V; Goel A
    Acta Cytol; 2022; 66(5):449-456. PubMed ID: 35413720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Indian Academy of Cytologists Guidelines for Reporting Serous Effusions: An Institutional Experience.
    Kundu R; Srinivasan R; Dey P; Gupta N; Gupta P; Rohilla M; Gupta S; Bal A; Rajwanshi A
    J Cytol; 2021; 38(1):1-7. PubMed ID: 33935385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Novel Tiered Reporting System in Serous Fluid Cytology and Risk of Malignancy Assessment: A Retrospective Study in a Tertiary Care Center.
    Alashetty S; Sadasivan B; Dharmalingam P; Rajagopal N; Kavya L; Pai MM
    J Cytol; 2023; 40(3):107-113. PubMed ID: 37745807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering Serous Effusions Using the New International System for Reporting Serous Fluid Cytopathology.
    Mandava H; Venkata Renuka I; Potti R; Mounica B; Kalla I
    Cureus; 2024 May; 16(5):e60042. PubMed ID: 38774462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk.
    Wang M; Sun T; Jiao J; Wang H
    Cancer Cytopathol; 2023 Jul; 131(7):433-441. PubMed ID: 36973963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy.
    Jha S; Sethy M; Adhya AK
    Diagn Cytopathol; 2021 Oct; 49(10):1089-1098. PubMed ID: 34289263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) in reporting serous effusion: A retrospective study.
    Yang H; Zhu J; Wang P
    Medicine (Baltimore); 2023 Oct; 102(43):e35707. PubMed ID: 37904355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the International System for Reporting Serous Fluid Cytopathology (TIS): A retrospective institutional study.
    Straccia P; Chiappetta M; Magnini D; Cancellieri A
    Cytopathology; 2022 May; 33(3):305-311. PubMed ID: 35213747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of cytology in distinguishing malignant mesothelioma: An institutional experience of 210 cases reclassified according to the International System for Reporting Serous Fluid Cytopathology (ISRSFC).
    Straccia P; Magnini D; Trisolini R; Lococo F; Chiappetta M; Cancellieri A
    Cytopathology; 2022 Jan; 33(1):77-83. PubMed ID: 34046958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Categorisation of peritoneal serous effusions using the International System for Reporting Serous Fluid Cytopathology-A study on gynaecological samples.
    Rakheja G; Singh M; Priyadarshnee B; Marimuthu B; Dhar L; Jain S; Khurana N; Rathore A
    Cytopathology; 2023 Mar; 34(2):138-145. PubMed ID: 36530023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the Indian Academy of Cytologists Recommendations for Reporting Serous Fluid Cytopathology in Routine Reporting of Ascitic Fluid Specimen and Assessment of the Risk of Malignancy.
    Jha S; Sethy M; Adhya AK
    J Cytol; 2022; 39(2):72-77. PubMed ID: 35814873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi-institutional study in Taiwan.
    Lu CH; Liu CY; Jhuang JY; Chen CC
    Cancer Cytopathol; 2024 Mar; 132(3):169-178. PubMed ID: 38062987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.